Indeed, members of the nuclear hormone receptor family, including RXRA, have been intensively studied as targets for therapeutic drugs for human diseases such as type II diabetes, obesity, and cancer [56]. The gene discussed is RXRA; the disease is obesity due to melanocortin 4 receptor deficiency.